Tag: iquid biopsy market report

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Liquid Biopsy Market from 2024 to 2033?

The liquid biopsy market size has seen exponential growth in recent years. It is projected to grow from $6.61 billion in 2023 to $8.64 billion in 2024, with a CAGR of 30.8%. Growth drivers include advances in cancer research, non-invasive procedures, personalized medicine, regulatory approvals, and early cancer detection.

The liquid biopsy market is projected to see exponential growth, reaching $27.44 billion by 2028 at a CAGR of 33.5%. Growth is driven by cancer monitoring, emerging technologies, and biomarker discovery. Trends include cancer detection, therapeutic monitoring, and minimal residual disease monitoring.

Claim Your Free Sample of the Global Liquid Biopsy Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2815&type=smp

What Key Factors Are Fueling the Growth of the Liquid Biopsy Market?

Government funding for cancer research is fueling the growth of the liquid biopsy market. Funding from government agencies, such as the National Cancer Institute (NCI), supports research in cancer detection and treatment. In 2021, NCI increased its grants for cancer research, and in 2022, the National Institutes of Health (NIH) allocated $6.9 billion to cancer research. These government investments are positively impacting the growth of the liquid biopsy market.

What Are the Major Segments of the Liquid Biopsy Market?

1) By Product: Assays Kits, Instruments, Services

2) By Clinical Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics

3) By End User: Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers

What New Trends Are Transforming the Liquid Biopsy Market?

Companies are focusing on advanced product launches in the liquid biopsy market to meet growing demand and gain a competitive edge. Laboratory Corporation of America Holdings launched the Labcorp Plasma Focus liquid biopsy test in June 2023, which helps oncologists develop personalized treatment strategies for patients with advanced tumors.

Order Now for Fast Delivery of Your Liquid Biopsy Market Report!

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Which Regions Are Driving Growth in the Liquid Biopsy Market?

North America was the largest region in the liquid biopsy market in 2023. Western Europe was the second largest region in the liquid biopsy market. The regions covered in the liquid biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Liquid Biopsy Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the liquid biopsy market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Liquid Biopsy Market Include

1. Liquid Biopsy Market Executive Summary

2. Liquid Biopsy Market Segments

3. Liquid Biopsy Market Size And Template Market Growth Rate

4. Key Liquid Biopsy Market Trends

5. Major Liquid Biopsy Market Drivers

……

25. Key Mergers And Acquisitions In The Liquid Biopsy Market

26. Top Liquid Biopsy Companies

27. Liquid Biopsy Market Opportunities And Strategies

28. Liquid Biopsy Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Biophotonics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biophotonics-global-market-report

Global Biopsy Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

#Ultrasound Systems Devices and Equipment Global Market Report 20243

#https://www.thebusinessresearchcompany.com/report/ultrasound-systems-devices-and-equipment-global-market-report3

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The liquid biopsy market has experienced a remarkable surge in recent years, demonstrating exponential growth from $6.61 billion in 2023 to an anticipated $8.64 billion in 2024, boasting an outstanding Compound Annual Growth Rate (CAGR) of 30.8%. This growth surge is attributed to significant advances in cancer research, the non-invasiveness of liquid biopsies, personalized medicine trends, regulatory approvals, and the crucial aspect of early cancer detection.

Anticipated Growth: A Glimpse into the Future
The market is poised for continued strength, with projections indicating a meteoric rise to $27.44 billion in 2028, showcasing an even more impressive CAGR of 33.5%. The anticipated growth is fueled by expanding applications, cancer monitoring, emerging technologies, the role of liquid biopsy in companion diagnostics, and the continued exploration of biomarkers. Notable trends in this forecast period include cancer detection and monitoring, therapeutic monitoring, minimal residual disease (MRD) monitoring, and the exploration of liquid biopsy in non-oncological applications.

Growing Prevalence Of Cancer Driving Liquid Biopsy Market Growth

• Rising Cancer Cases: The increasing prevalence of cancer is a key driving force behind the growth of the liquid biopsy market.
• Cancer-Specific Biomarkers: Liquid biopsy detects cancer-specific biomarkers like circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs), enabling non-invasive cancer diagnosis and monitoring.
• Statistics by ACS: According to the American Cancer Society Inc., over 1.9 million new cancer cases are expected to be diagnosed in the USA in 2023.
• Market Leaders: Major players in this market include QIAGEN NV, Roche Diagnostics Ltd., Bio-Rad Laboratories Inc., and others.

Increasing Focus On Introducing Large Liquid Biopsy Panels To Gain A Competitive Edge

• Strategic Innovation: Major companies are strategically developing large liquid biopsy panels to gain a competitive edge.
• Comprehensive Disease Monitoring: Large liquid biopsy panels analyze various biomarkers to detect and monitor a wide range of diseases, with a primary focus on cancer.
• Tempus Labs Inc.’s xF+ Panel: In June 2022, Tempus Labs Inc. launched its largest clinically available liquid biopsy panel, xF+, covering a broader range of genes and incorporating predictive biomarkers for the effectiveness of cancer immunotherapies.

View More On The Liquid Biopsy Market Report 2024 – https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

 Strategic Acquisitions: Quest Diagnostics and Haystack Oncology Inc.

• Quest Diagnostics Acquisition: In June 2021, Quest Diagnostics acquired Haystack Oncology Inc., a move aimed at incorporating MRD liquid biopsy technology into Quest Diagnostics’ cancer diagnostics portfolio.
• Early Detection Capability: The acquisition enhances the ability to detect residual or recurring cancer early, providing crucial guidance for treatment choices.
• Liquid Biopsy Pioneer: Haystack Oncology Inc. is recognized for its contribution as a provider of liquid biopsy technology.

Market Segmentation for Comprehensive Insights

• By Product: Assays Kits, Instruments, Services.
• By Clinical Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics.
• By End User: Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers.

Regional Dominance: North America Takes the Lead

• North America: Emerging as the largest region in the liquid biopsy market in 2023, showcasing the region’s significant contribution to market growth.

In conclusion, the liquid biopsy market is not only witnessing exceptional growth but is also reshaping the landscape of cancer diagnostics. The emphasis on non-invasiveness, personalized medicine, and the continuous exploration of innovative technologies positions liquid biopsy as a transformative tool in the fight against cancer. As the market continues to evolve, collaborations, strategic acquisitions, and the development of comprehensive panels are expected to drive further advancements, offering new avenues for early detection and personalized treatment strategies.

Request A Sample Of The Global Liquid Biopsy Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=2815&type=smp